Jazz Pharmaceuticals (JAZZ) Change in Inventory (2010 - 2026)

Jazz Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at $77.8 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 118.54% year-over-year to $77.8 million in Q1 2026; TTM through Mar 2026 was $128.2 million, a 87.77% increase from a year earlier, with the FY2025 full-year figure at $86.0 million, up 88.93% from the prior year.
• Change in Inventory advanced to $77.8 million in Q1 2026 per JAZZ's latest filing, from -$7.7 million in the prior quarter.
• Across five years, Change in Inventory topped out at $77.8 million in Q1 2026 and bottomed at -$7.7 million in Q4 2025.
• The 5-year median for Change in Inventory is $9.3 million (2024), against an average of $16.0 million.
• Across the five-year window, Change in Inventory surged 1229.42% in 2024 and plunged 141.36% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$816000.0 in 2022, then soared by 272.06% to $1.4 million in 2023, then jumped by 1229.42% to $18.7 million in 2024, then sank by 141.36% to -$7.7 million in 2025, then jumped by 1107.77% to $77.8 million in 2026.
• Per Business Quant, the three latest JAZZ Change in Inventory figures stand at $77.8 million (Q1 2026), -$7.7 million (Q4 2025), and $31.9 million (Q3 2025).